China SXT Pharmaceuticals SXTC
$ 0.35
2.65%
Annual report 2024
added 12-21-2024
Country |
China |
IPO year |
2019 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Feng Zhou |
Employees in the company |
97 |
Shares |
867 K |
Market Cap[1] |
$ 304 K |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.